Body and Mind Inc. (BAMM.CN)
CAD 0.03
(0.0%)
CAD 0.03
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 19.89 Million USD | 47.09% |
| 2022 | 13.52 Million USD | 71.19% |
| 2021 | 7.9 Million USD | 199.79% |
| 2020 | 2.63 Million USD | 0.0% |
| 2019 | - USD | -100.0% |
| 2018 | 2.17 Million USD | 0.0% |
| 2017 | - USD | -100.0% |
| 2016 | 76.04 Thousand USD | 10.07% |
| 2015 | 69.09 Thousand USD | -11.83% |
| 2014 | 78.35 Thousand USD | -13.99% |
| 2013 | 91.1 Thousand USD | 75.93% |
| 2012 | 51.78 Thousand USD | -11.48% |
| 2011 | 58.49 Thousand USD | 12.33% |
| 2010 | 52.07 Thousand USD | 417.45% |
| 2009 | 10.06 Thousand USD | 0.0% |
| 2008 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 12.25 Million USD | -1.31% |
| 2024 Q2 | 12.42 Million USD | -9.81% |
| 2024 Q1 | 13.77 Million USD | -30.77% |
| 2023 Q1 | 13.54 Million USD | 0.12% |
| 2023 Q3 | 20.14 Million USD | 7.04% |
| 2023 Q4 | 19.89 Million USD | -1.22% |
| 2023 Q2 | 18.81 Million USD | 38.95% |
| 2023 FY | 19.89 Million USD | 47.09% |
| 2022 Q3 | 13.44 Million USD | 3.87% |
| 2022 Q2 | 12.94 Million USD | 59.37% |
| 2022 Q1 | 8.12 Million USD | 2.79% |
| 2022 Q4 | 13.52 Million USD | 0.61% |
| 2022 FY | 13.52 Million USD | 71.19% |
| 2021 Q2 | 2.56 Million USD | -2.11% |
| 2021 FY | 7.9 Million USD | 199.79% |
| 2021 Q1 | 2.62 Million USD | -0.49% |
| 2021 Q3 | 2.67 Million USD | 4.04% |
| 2021 Q4 | 7.9 Million USD | 195.81% |
| 2020 Q1 | 1.14 Million USD | 0.0% |
| 2020 FY | 2.63 Million USD | 0.0% |
| 2020 Q4 | 2.63 Million USD | 23.75% |
| 2020 Q3 | 2.12 Million USD | 93.31% |
| 2020 Q2 | 1.1 Million USD | -3.7% |
| 2019 Q2 | 5.5 Million USD | 153.05% |
| 2019 FY | - USD | -100.0% |
| 2019 Q4 | - USD | -100.0% |
| 2019 Q1 | 2.17 Million USD | 0.0% |
| 2019 Q3 | 5.78 Million USD | 5.11% |
| 2018 Q4 | 2.17 Million USD | 11.7% |
| 2018 Q2 | 2.17 Million USD | 0.0% |
| 2018 FY | 2.17 Million USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q3 | 1.94 Million USD | -10.48% |
| 2017 Q3 | - USD | -100.0% |
| 2017 Q2 | 92.65 Thousand USD | 25.46% |
| 2017 Q1 | 73.85 Thousand USD | -2.89% |
| 2017 FY | - USD | -100.0% |
| 2017 Q4 | - USD | 0.0% |
| 2016 Q1 | 69.79 Thousand USD | 1.01% |
| 2016 FY | 76.04 Thousand USD | 10.07% |
| 2016 Q4 | 76.04 Thousand USD | -2.84% |
| 2016 Q3 | 78.26 Thousand USD | 19.9% |
| 2016 Q2 | 65.28 Thousand USD | -6.46% |
| 2015 FY | 69.09 Thousand USD | -11.83% |
| 2015 Q4 | 69.09 Thousand USD | -5.86% |
| 2015 Q3 | 73.39 Thousand USD | 5.79% |
| 2015 Q2 | 69.37 Thousand USD | -9.61% |
| 2015 Q1 | 76.74 Thousand USD | -2.06% |
| 2014 Q1 | 94.56 Thousand USD | 3.81% |
| 2014 FY | 78.35 Thousand USD | -13.99% |
| 2014 Q3 | 76.78 Thousand USD | 3.16% |
| 2014 Q4 | 78.35 Thousand USD | 2.05% |
| 2014 Q2 | 74.43 Thousand USD | -21.29% |
| 2013 Q2 | 88.79 Thousand USD | 14.36% |
| 2013 Q4 | 91.1 Thousand USD | 0.78% |
| 2013 Q1 | 77.64 Thousand USD | 49.94% |
| 2013 FY | 91.1 Thousand USD | 75.93% |
| 2013 Q3 | 90.39 Thousand USD | 1.8% |
| 2012 Q2 | 50.5 Thousand USD | -11.5% |
| 2012 Q1 | 57.06 Thousand USD | -2.44% |
| 2012 Q3 | 51.95 Thousand USD | 2.87% |
| 2012 Q4 | 51.78 Thousand USD | -0.33% |
| 2012 FY | 51.78 Thousand USD | -11.48% |
| 2011 Q3 | 57.88 Thousand USD | 3.4% |
| 2011 Q4 | 58.49 Thousand USD | 1.05% |
| 2011 Q2 | 55.98 Thousand USD | 5.26% |
| 2011 Q1 | 53.18 Thousand USD | 2.13% |
| 2011 FY | 58.49 Thousand USD | 12.33% |
| 2010 Q2 | 15.02 Thousand USD | 7.35% |
| 2010 FY | 52.07 Thousand USD | 417.45% |
| 2010 Q1 | 13.99 Thousand USD | 39.08% |
| 2010 Q4 | 52.07 Thousand USD | 2.1% |
| 2010 Q3 | 51 Thousand USD | 239.43% |
| 2009 FY | 10.06 Thousand USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | 10.06 Thousand USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Aion Therapeutic Inc. | 826.47 Thousand CAD | -2307.205% |
| Ayurcann Holdings Corp. | 709.07 Thousand CAD | -2705.759% |
| Blueberries Medical Corp. | 12.8 Thousand CAD | -155279.756% |
| The BC Bud Corporation | 229.35 Thousand CAD | -8574.249% |
| BioNxt Solutions Inc. | 4.89 Million CAD | -306.502% |
| CordovaCann Corp. | 6.37 Million CAD | -211.86% |
| Christina Lake Cannabis Corp. | 6.09 Million CAD | -226.351% |
| Captor Capital Corp. | 6.71 Million CAD | -196.274% |
| City View Green Holdings Inc. | 1.49 Million CAD | -1227.588% |
| 1CM Inc. | 6.39 Million CAD | -211.138% |
| Global Hemp Group Inc. | 3.55 Million CAD | -459.374% |
| Greenway Greenhouse Cannabis Corporation | 16.02 Million CAD | -24.185% |
| IM Cannabis Corp. | 13.78 Million CAD | -44.354% |
| Lobe Sciences Ltd. | 332.64 Thousand CAD | -5880.887% |
| Maple Leaf Green World Inc. | 2.47 Million CAD | -703.775% |
| Mountain Valley MD Holdings Inc. | - CAD | -Infinity% |
| Nextleaf Solutions Ltd. | 449.74 Thousand CAD | -4323.569% |
| Ovation Science Inc. | 192.61 Thousand CAD | -10228.803% |
| Pharmadrug Inc. | 1.76 Million CAD | -1026.024% |
| Captiva Verde Wellness Corp. | 191.7 Thousand CAD | -10277.887% |
| RAMM Pharma Corp. | 405.14 Thousand CAD | -4810.605% |
| RIV Capital Inc. | 6.59 Million CAD | -201.757% |
| Revive Therapeutics Ltd. | 25.21 Thousand CAD | -78797.621% |
| Red White & Bloom Brands Inc. | 262.13 Million CAD | 92.41% |
| SLANG Worldwide Inc. | 29.86 Million CAD | 33.389% |
| 1933 Industries Inc. | 17.57 Million CAD | -13.225% |
| Red Light Holland Corp. | 811.04 Thousand CAD | -2352.98% |
| Top Strike Resources Corp. | 13.29 Million CAD | -49.694% |
| Xebra Brands Ltd. | - CAD | -Infinity% |
| Adastra Holdings Ltd. | 3.58 Million CAD | -455.212% |